Form 4 for IMRX Immuneering Corp

Accepted 2021-08-04 00:00:00 ET · period of report 2021-08-03 · accession 0001104659-21-099741 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2021-08-04	2021-08-03	IMRX	Zeskind Benjamin J.	Pres, CEO, Dir, 10%	C - Cnv Deriv	—	+49.1K	2.60M	+2%	—
D	2021-08-04	2021-08-03	IMRX	Zeskind Benjamin J.	Pres, CEO, Dir, 10%	P - Purchase	$15.00	+2,098	2.60M	+0.1%	+$31.5K
DM	2021-08-04	2021-08-03	IMRX	Zeskind Benjamin J.	Pres, CEO, Dir, 10%	C - Cnv Deriv	—	-49.1K	0	-100%	—

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Class A Common Stock	2021-08-03	C	A	49,099	—	2,598,171	D	—	—	(F1) Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's Class A common stock on a one-for-one basis.
2	Common	Class A Common Stock	2021-08-03	P	A	2,098	$15.00	2,600,269	D	—	—
3	Derivative	Series A Preferred Stock	2021-08-03	C	D	40,928	—	0	D	— · — to —	40,928 Class A Common Stock	(F1) Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's Class A common stock on a one-for-one basis.
4	Derivative	Series B Preferred Stock	2021-08-03	C	D	8,171	—	0	D	— · — to —	8,171 Class A Common Stock	(F1) Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's Class A common stock on a one-for-one basis.